I ask my professional contacts and colleagues to follow this model. Please block all anonymous accounts. The tone of these accounts has become increasing aggressive and harmful. They do not deserve your attention. If you follow, you are endorsing this behavior on #medtwitter
We have chosen to block all anonymous accounts as they do not represent our views. We recommend that our followers block them as well. Please do not ask us to respond to any content from anonymous accounts as they are not on our feed and not worthy of our (and your) attention.
Live @SIRspecialists Publication Alert!!!
The 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: Pertinent Points for the Interventional Radiologist jvir.org/article/S1051-0443%…
Live @PERTConsortium Publication Alert!!!
The largest registry report on Acute Pulm Emb ever Pulmonary Embolism in the United States: A Report From the National PERT Consortium - Journal of the Society for Cardiovascular Angiography & Interventions jscai.org/article/S2772-9303…
Examining the applications of embolization, a group from @IcahnMountSinai details how excellence can be achieved across diverse applications, underscoring the importance of technique refinement, cross-specialty collaboration, & procedural standardization. evtoday.com/articles/2026-ap…
#SIRTOR26 incredible memories...proud to serve @SIRspecialists and appreciate what we have accomplished as a team of dedicated volunteers and inspiring professional staff. Already looking forward to #SIRLA27
Live @MountSinaiIR Publication Alert!! Incredible effort to set the standard for #LRT for #HCC
Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma | Radiology pubs.rsna.org/doi/10.1148/ra…
Live @MountSinaiIR we are proud to share we performed 56 outpt embolizations for UFE,PAE,GAE, and HAE at our Embolization Center of Excellence @MountSinaiNYC WestCampus in April. This is a testament to our MDs, nurses, technologists, office staff, and our patients. TYSM!!
STORM-PE 90-day results demonstrates greater improvement in functional outcomes using #CAVT compared to patients who received anticoagulation alone, reports @roblookstein, adding that CAVT patients walked "significantly farther" at follow-up #SIR26TOR@SIRspecialists
#SIR26TOR: 12-month IN.PACT AV Access post-approval study results show a 70% rate of target-lesion primary patency and 80.6% freedom from all-cause mortality in 159 patients, with no new safety concerns reported when compared to IN.PACT AV randomised controlled trial